These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 27311725

  • 1. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
    Wan MJ, Ullrich NJ, Manley PE, Kieran MW, Goumnerova LC, Heidary G.
    J Neurooncol; 2016 Aug; 129(1):173-8. PubMed ID: 27311725
    [Abstract] [Full Text] [Related]

  • 2. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
    Kalin-Hajdu E, Décarie JC, Marzouki M, Carret AS, Ospina LH.
    Pediatr Blood Cancer; 2014 Feb; 61(2):223-7. PubMed ID: 23956233
    [Abstract] [Full Text] [Related]

  • 3. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC.
    J AAPOS; 2010 Apr; 14(2):155-8. PubMed ID: 20451859
    [Abstract] [Full Text] [Related]

  • 4. Visual loss in orbitofacial neurofibromatosis type 1.
    Oystreck DT, Morales J, Chaudhry I, Alorainy IA, Elkhamary SM, Pasha TM, Bosley TM.
    Ophthalmology; 2012 Oct; 119(10):2168-73. PubMed ID: 22709421
    [Abstract] [Full Text] [Related]

  • 5. Neurofibromatosis Type 1-Associated Optic Pathway Glioma in Children: A Follow-Up of 10 Years or More.
    Kinori M, Armarnik S, Listernick R, Charrow J, Zeid JL.
    Am J Ophthalmol; 2021 Jan; 221():91-96. PubMed ID: 32283094
    [Abstract] [Full Text] [Related]

  • 6. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S, Flaherty M, Billson F, North K.
    Ophthalmology; 2004 Mar; 111(3):568-77. PubMed ID: 15019338
    [Abstract] [Full Text] [Related]

  • 7. Optic pathway glioma in children: does visual deficit correlate with radiology in focal exophytic lesions?
    Aquilina K, Daniels DJ, Spoudeas H, Phipps K, Gan HW, Boop FA.
    Childs Nerv Syst; 2015 Nov; 31(11):2041-9. PubMed ID: 26277358
    [Abstract] [Full Text] [Related]

  • 8. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
    Chang BC, Mirabella G, Yagev R, Banh M, Mezer E, Parkin PC, Westall CA, Buncic JR.
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2895-902. PubMed ID: 17525226
    [Abstract] [Full Text] [Related]

  • 9. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.
    Avery RA, Bouffet E, Packer RJ, Reginald A.
    Invest Ophthalmol Vis Sci; 2013 Feb 05; 54(2):1034-8. PubMed ID: 23329671
    [Abstract] [Full Text] [Related]

  • 10. Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.
    de Blank PM, Berman JI, Liu GT, Roberts TP, Fisher MJ.
    Neuro Oncol; 2013 Aug 05; 15(8):1088-95. PubMed ID: 23658320
    [Abstract] [Full Text] [Related]

  • 11. Optic pathway gliomas in children with and without neurofibromatosis 1.
    Czyzyk E, Jóźwiak S, Roszkowski M, Schwartz RA.
    J Child Neurol; 2003 Jul 05; 18(7):471-8. PubMed ID: 12940652
    [Abstract] [Full Text] [Related]

  • 12. Clinical Presentation and Outcome of Patients With Optic Pathway Glioma.
    Robert-Boire V, Rosca L, Samson Y, Ospina LH, Perreault S.
    Pediatr Neurol; 2017 Oct 05; 75():55-60. PubMed ID: 28847625
    [Abstract] [Full Text] [Related]

  • 13. The role of surgery in optic pathway/hypothalamic gliomas in children.
    Goodden J, Pizer B, Pettorini B, Williams D, Blair J, Didi M, Thorp N, Mallucci C.
    J Neurosurg Pediatr; 2014 Jan 05; 13(1):1-12. PubMed ID: 24138145
    [Abstract] [Full Text] [Related]

  • 14. Management options for visual pathway compression from optic gliomas.
    Bessero AC, Fraser C, Acheson J, Davagnanam I.
    Postgrad Med J; 2013 Jan 05; 89(1047):47-51. PubMed ID: 23001214
    [Abstract] [Full Text] [Related]

  • 15. Visual Outcomes After Treatment for Sporadic Optic Pathway Gliomas in Pediatric Patients: A Systematic Review.
    Shlobin NA, Montgomery EY, Mohammad LM, Kandula V, Beestrum M, DeCuypere M, Lam SK.
    World Neurosurg; 2022 Aug 05; 164():436-449.e2. PubMed ID: 35430402
    [Abstract] [Full Text] [Related]

  • 16. Visual loss in children with neurofibromatosis type 1 and optic pathway gliomas: relation to tumor location by magnetic resonance imaging.
    Balcer LJ, Liu GT, Heller G, Bilaniuk L, Volpe NJ, Galetta SL, Molloy PT, Phillips PC, Janss AJ, Vaughn S, Maguire MG.
    Am J Ophthalmol; 2001 Apr 05; 131(4):442-5. PubMed ID: 11292406
    [Abstract] [Full Text] [Related]

  • 17. Neurofibromatosis type 1 and sporadic optic gliomas.
    Singhal S, Birch JM, Kerr B, Lashford L, Evans DG.
    Arch Dis Child; 2002 Jul 05; 87(1):65-70. PubMed ID: 12089128
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1.
    Prada CE, Hufnagel RB, Hummel TR, Lovell AM, Hopkin RJ, Saal HM, Schorry EK.
    J Pediatr; 2015 Oct 05; 167(4):851-856.e1. PubMed ID: 26233602
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.